Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Fosun International Limited
  6. News
  7. Summary
    656   HK0656038673

FOSUN INTERNATIONAL LIMITED

(656)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

China's Fosun says willing to provide BioNTech vaccines to Taiwan

05/22/2021 | 05:20am EST

BEIJING, May 22 (Reuters) - China's Shanghai Fosun Pharmaceutical Group Co Ltd is willing to provide Taiwan with BioNTech COVID-19 vaccines, its chairman Wu Yifang told Xinhua news agency, amid a spike in domestic infections on the island.

Fosun signed a deal with BioNTech to exclusively develop and commercialise COVID-19 vaccine products developed using BioNTech's mRNA technology in mainland China, Hong Kong, Macau and Taiwan.

BioNTech's development and distribution partner for the rest of the world is U.S. firm Pfizer Inc.

Wu said certain groups in Taiwan he did not name had been in touch for an emergency purchase of vaccines and the company was willing to "provide vaccine services to Taiwan compatriots".

Since last year, Fosun has been promoting vaccines for Taiwan, Wu said, adding they hope shots can arrive on the island soon to help prevent a resurgent spread of the virus.

Fosun did not immediately reply to a Reuters request for comment.

Taiwan's government has said it is talking with BioNTech rather than Fosun, and that the two sides were on the verge of announcing a deal in December when BioNTech pulled the plug.

Taiwan has implied China was to blame for the failed deal, while China has blamed Taiwan for trying to circumvent Fosun.

BioNTech said in February it planned to provide the vaccine to Taiwan, but has not provided further details and declined to comment on the progress of talks in a statement to Reuters this week.

China claims Taiwan as its own territory, and has repeatedly sparred with the island over the coronavirus pandemic. Taiwan has accused China of spreading fake news, which Beijing denies.

Taiwan has received only around 700,000 vaccine doses to date, all from AstraZeneca Plc, and those are rapidly running out as it steps up vaccinations during a spike in domestic infections.

Taiwan has millions more doses on order, including from Moderna Inc, but like many other parts of the world has faced delivery delays due to global shortages. (Reporting by Beijing newsroom; Writing by Ben Blanchard; Editing by Lincoln Feast.)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.49% 8191 Delayed Quote.11.84%
BIONTECH SE 3.17% 344.06 Delayed Quote.310.30%
FOSUN INTERNATIONAL LIMITED 0.11% 8.89 End-of-day quote.-27.01%
MODERNA, INC. 1.73% 306.72 Delayed Quote.193.60%
MSCI TAIWAN (STRD) -0.38% 721.191 Real-time Quote.18.81%
PFIZER, INC. 2.32% 54.27 Delayed Quote.44.09%
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 0.13% 53.07 End-of-day quote.-1.70%
All news about FOSUN INTERNATIONAL LIMITED
12/03FOSUN INTERNATIONAL : Pharma Participates in the BEYOND Expo Presents innovation-driven ec..
PU
11/29FOSUN INTERNATIONAL : Wolves Academy Partner with Chicago City Soccer Club
PU
11/26FOSUN INTERNATIONAL : Participates in the Inaugural Asia Summit on Global Health, Actively..
PU
11/23FOSUN INTERNATIONAL : Lanvin Group Unveils New Brand Identity
PU
11/23NATURE : Making Biologic Medicines More Accessible
PU
11/18ORIENTAL AESTHETICS BRINGS OUT THE B : the 10th Shanghai Haute Couture Week Successfully C..
PU
11/09With the "In-house Counsel of the Year" award given to the insurance industry, Fidelida..
PU
11/08FOSUN INTERNATIONAL : joins hands with Standard Chartered Bank to create the global ESG im..
PU
11/05Focusing on Family Customers to Promote the “Dual Circulation” Strategy, Fo..
PU
11/02NATURE DIALOGUE WITH DR. AIMIN HUI, : Leveraging global strength in drug development
PU
More news
Analyst Recommendations on FOSUN INTERNATIONAL LIMITED
More recommendations
Financials
Sales 2021 155 B 24 321 M 24 321 M
Net income 2021 12 046 M 1 889 M 1 889 M
Net Debt 2021 126 B 19 749 M 19 749 M
P/E ratio 2021 4,97x
Yield 2021 4,62%
Capitalization 60 542 M 9 495 M 9 496 M
EV / Sales 2021 1,20x
EV / Sales 2022 1,14x
Nbr of Employees 78 000
Free-Float 27,4%
Chart FOSUN INTERNATIONAL LIMITED
Duration : Period :
Fosun International Limited Technical Analysis Chart | 656 | HK0656038673 | MarketScreener
Technical analysis trends FOSUN INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 7,27 CNY
Average target price 11,07 CNY
Spread / Average Target 52,2%
EPS Revisions
Managers and Directors
Qi Yu Chen Co-Chief Executive Officer & Executive Director
Xiao Liang Xu Co-Chief Executive Officer & Executive Director
Ping Gong Chief Financial Officer & Executive Director
Hou Lin Zhang Co-Chief Financial Officer & Senior Vice President
Li Gang Zhang Co-CFO & GM-Financial Management
Sector and Competitors
1st jan.Capi. (M$)
FOSUN INTERNATIONAL LIMITED-27.01%9 495
ALLIANZ SE-1.16%91 466
MARSH & MCLENNAN COMPANIES, INC.39.95%84 716
CHUBB LIMITED13.79%78 162
ZURICH INSURANCE GROUP LTD3.21%62 280
BAJAJ FINSERV LIMITED99.39%36 985